BioContact Québec

BioContact Québec

October 04, 2005 08:30 ET

Media Advisory: Biocontact Quebec 12th Edition Starts Tomorrow With a Special Session on International Financing

QUEBEC, QUEBEC--(CCNMatthews - Oct. 4, 2005) - The leading Canadian biopharmaceutical partnership symposium, BioContact Quebec 2005 kicks off this Wednesday in Quebec City with more than 150 top financial, investment and biopharmaceutical companies and 1200 participants from around the world including the United States, Asia and Europe.

OPENING ADDRESS

On Wednesday October 5th, Mary Macdonald, Vice-President, Investment Banking Segment, Canada, Thomson Macdonald will present the opening address with her analysis of the Canadian biotech sector. Ms. Macdonald's conference will tackle the important question "are the early VC investments starting to pay off?" Her update on the biotech industry is not to be missed!

INTERNATIONAL FINANCING SESSION

Also not to be missed is the special International Financing Session on Wednesday October 5th from 2 pm till 5 pm. BioContact Quebec will host two panels of leading figures in the US financial community who all share a common interest in expanding their involvement with Canadian companies. The first panel will consist of venture capital and private equity investors. The second one will be composed of investment bankers of various sizes and interests actively engaged in raising funds for Canadian life sciences companies.

Here is an overview of the 12th edition of BioContact Quebec for Wednesday, October 5th, 2005:



OPENING ADDRESS - 1:15pm - 2 pm
"Are the early VC investments starting to pay off"
Bal Room
Mary Macdonald
Investment Banking Segment, Canada
Thomson Macdonald

INTERNATIONAL FINANCING SESSION - 2 pm - 5 pm
Salon Rose
Chaiman: Elie Farah, Montreal International
Moderator: Stephen M. Nagler, TriState Ventures LLC


Venture Capital panel: Investment Banking:
---------------------- -------------------
Thomas McNearny - Alex Zisson Bear Stearns - Nikhil Puri
Proquest Investments Punk, Ziegel & Company
- Jay Moorin - Ed Gordon
Vantage Point Venture Partners Equity Capital Markets, HSBC
Atlas Venture - Paul Pospisil - Jim Rossman
IBM - Alfredo Boratto Maxim Group - Anthony Sarkis
- Richard Meadows Needham & Company LLC
- Simon Gill


BioContact Quebec 2005 is a unique opportunity to get the inside scoop on the biopharmaceutical sector. A detailed symposium agenda and a list of all participants are available on BioContact Quebec 2005 website: www.biocontact.qc.ca.

MEDIA

A media room will be available throughout the conference. A communications officer will be on-site to help media schedule interviews and meetings.

Contact Information

  • BioContact Quebec 2005
    Anie Perrault
    (514) 258-7629